Clinical trial · Interventional
Breast, Omega 3 Free Fatty Acid, Ph 0
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119)
NCT02996240CI-TRIAL-00050708completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Assess the impact of dietary omega 3 free fatty acids breast cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breastcancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Omega-3 FFA | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Omega-3 FFA
- description
- Patients will take 12 capsules daily with meals, divided twice daily (example, 6 with breakfast and 6 with dinner).
- interventionNames
- Dietary Supplement: Omega-3 FFA
Primary outcomes (4)
- measure
- Change in serum colony stimulating factor at surgery
- timeFrame
- 30 days
- measure
- Change in circulating levels of pro-inflammatory cytokines.
- timeFrame
- 30 days
- measure
- Change in circulating levels of eicosanoids.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * At least 18 years of age * ECOG ≤2 * Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB/Ethics Committee * Consented for tissue collection on CTRC repository 07-32 Exclusion Criteria: * Active systemic illness (infection including viral illnesses such as Hepatitis and HIV) * Chronic use of NSAIDs or omega-3 free fatty acid supplementation within the last 60 days (defined as greater than or equal to 7 consecutive days) * Any NSAIDs or omega-3 free fatty acid supplementation within the last 14 days * History of medical noncompliance * Scheduled date of surgical resection that would limit the amount of time taking the intervention to less than 21 days
References
Publications (0)
Data not yet available
No reference posted for this study.